E176: Q1 Anesthesia Market Update with LocumT...

In Part Two of our financial deep dive with Vinny Cagungun, we tackle four of the most-requested topics from our listeners: debt payoff strategy, the real financial differences between W2 and 1099, tax planning for high-income CRNAs, and how to find the right advisors for your te ...  Show more

What happens when both you and your significant other are on the CRNA journey? In this episode, Cole and Tanner sit down with Connor and Shayla to talk about what it’s really like navigating anesthesia school as a couple.From supporting each other, overlapping in school, managing ...  Show more

Lipid Drugs: Part 1

Guest: Alicia A. Mickow, APRN, C.N.P., M.S.N

Host: Stephen L. Kopecky, M.D.

In Part 1 of this two-part series, listeners will learn the challenges of managing patients who are statin-intolerant, the range of available ...

Ozempic. Developed as diabetes medication. Adopted as a weight loss drug. Eyed for its potential neuroprotective effects.

Hollywood's popularization of Ozempic as a way to lose weight has made it one of the most widely-discussed drugs of our time, an ...

In this episode, hosts Drs. Peter Lu and Jason Silverman talk to Dr. Rima Fawaz about the role of GLP-1 receptor ...

In this episode, Dr. K breaks down the hype around dopamine detoxes and social media breaks—and why they don’t actually solve the problem. Drawing on his background in addiction psychiatry, he explains that detoxing only pauses the cycle temporarily; if you go back to the same ha ...  Show more